Abstract
We carried out a prospective study on clinical variables and functions of polymorphonuclear leukocytes (PMNs) of 20 patients with early rheumatoid arthritis (RA) and compared the results with the presence of erosions before treatment and at a one-year follow-up. Migration of PMNs determined by agarose and filter assays and respiratory burst of PMNs determined by luminol-enhanced chemiluminescence (CL) test were studied both before starting RA-modifying treatment and 6–12 (mean 7.3) months later. PMNs of the patients without erosions at one year, as compared to the patients with erosions, showed significantly depressed migration into filter and significantly depressed CL responses toN-formyl-methionyl-leucyl-phenylalanine, both before starting the treatment and at 7.3 months. Although causality remains uncertain, the results suggest that depressed functional capacity of PMNs is associated with low risk of joint destruction in early RA.
Similar content being viewed by others
References
Larsen, A., andJ. Thoen. 1987. Hand radiography of 200 patients with rheumatoid arthritis repeated after an interval of one year.Scand. J. Rheumatol. 16:395–401.
Van Der Heijde, D. M. F. M., M. A. Van Leeuwen, P. L. C. M. Van Riel, A. M. Koster, M. A. Van't Hof, M. H. Van Rijswijk, andL. B. Van Der Putte. 1992. Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis.Arthritis Rheum. 35:26–34.
Fleming, A., J. M. Crown, andM. Corbett. 1976. Prognostic value of early features in rheumatoid disease.Br. Med. J. 1:1243–1245.
Haataja, M., andL. J. KalliomÄki. 1978. Inter-relationship of laboratory variables in rheumatoid arthritis.J. Rheumatol. 5:263–266.
Möttönen, T. 1988. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis.Ann. Rheum. Dis. 47:648–653.
Dawes, P. T., P. D. Fowler, andR. Jackson. 1986. Prediction of progressive joint damage in patients with rheumatoid arthritis receiving gold orD-penicillamine therapy.Ann. Rheum. Dis. 45:945–949.
Capell, H. A., D. Lewis, andJ. Carey. 1986. A three-year follow-up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis.Ann. Rheum. Dis. 45:705–711.
Harris, E. D., Jr. 1990. Rheumatoid arthritis. Pathophysiology and implications for therapy.N. Engl. J. Med. 322:1277–1289.
Mohr, W., H. Westerhellweg, andD. Wessinghage. 1981. Polymorphonuclear granulocytes in rheumatic tissue destruction. III. An electron microscopic study of PMNs at the pannuscartilage junction in rheumatoid arthritis.Ann. Rheum. Dis. 40:396–399.
Konttinen, Y. T., V. Bergroth, D. Nordström, K. Koota, B. Skrifvars, G. Hagman, C. Friman, M. HÄmÄlÄinen, andP. SlÄtis. 1985. Cellular immunohistopathology of acute, subacute and chronic synovitis in rheumatoid arthritis.Ann. Rheum. Dis. 44:549–555.
Jose, P. J., I. K. Moss, R. N. Maini, andT. J. Williams. 1990. Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: Role of C5a in the acute inflammatory phase.Ann. Rheum. Dis. 49:747–752.
Weiss, S. J. 1989. Tissue destruction by neutrophils.N. Engl. J. Med. 320:365–376.
Mowat, A. G., andJ. Baum. 1971. Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis.J. Clin. Invest. 50:2541–2549.
Roberts-Thompson, P. J., B. L. Hazlemann, I. G. Barnett, I. C. M. Maclennan, andA. G. Mowat. 1976. Factors relating to circulating immune complexes in rheumatoid arthritis.Ann. Rheum. Dis. 35:314–320.
Goddard, D. H., A. P. Kirk, J. R. Kirwan, G. D. Johnson, andE. J. Holborow. 1984. Impaired polymorphonuclear leukocyte chemotaxis in rheumatoid arthritis.Ann. Rheum. Dis. 43:151–156.
Elmgren, J., andT. H. Hansen. 1985. Subnormal sensitivity of neutrophils to complement split product C5a in rheumatoid arthritis: Relation to complement catabolism and disease extent.Ann. Rheum. Dis. 44:514–518.
Turner, R. A., J. A. Johnson, andS. R. Turner. 1987. Neutrophil responsiveness to chemoattractant tripeptide in rheumatoid arthritis.Proc. Soc. Exp. Biol. Med. 186:125–133.
Howe, G. B., J. N. Fordham, K. A. Brown, andH. L. F. Currey. 1981. Polymorphonuclear cell function in rheumatoid arthritis and Felly's syndrome.Ann. Rheum. Dis. 40:370–375.
King, S. L., J. Parker, R. Cooper, R. Sturrock, andC. G. Gemmel. 1986. Polymorphonuclear leucocyte function in rheumatoid arthritis.Br. J. Rheumatol. 25:26–33.
Brown, K. A. 1988. The polymorphonuclear cell in rheumatoid arthritis.Br. J. Rheumatol. 27:150–155.
Espersen, G. T., E. Ernst, M. Vestergaard, J. O. Pedersen, andN. Grunnet. 1989. Changes in PMN leukocyte migration activity and complement C3d levels in RA patients with high disease activity during steroid treatment.Scand. J. Rheumatol. 18:51–56.
Chiu, P. L., P. Davis, K. Wong, andM. Dasgupta. 1983. Superoxide production in neutrophils of patients with rheumatoid arthritis and Felly's syndrome.J. Rheumatol. 10:694–700.
Davis, P., andC. Johnston. 1986. Effects of gold compounds on function of phagocytic cells. Comparative inhibition of activated polymorphonuclear leukocytes and monocytes from rheumatoid arthritis and control subjects.Inflammation 10:311–320.
Biemond, P., A. J. G. Swaak, J. M. A. Penders, C. M. Beindorf, andJ. F. Koster. 1986. Superoxide production by polymorphonuclear leucocytes in rheumatoid arthritis and osteoarthritis: In vivo inhibition by antirheumatic drug piroxicam due to interference with the activation of the NADPH-oxidase.Ann. Rheum. Dis. 45:249–255.
Ropes, M. W., G. A. Bennett, S. Cobb, R. Jacox, andR. A. Jessar. 1958. 1958 revision of diagnostic criteria for rheumatoid arthritis.Bull. Rheum. Dis. 9:175–176.
Ritchie, D. M., J. A. Boyle, J. M. McInnes, M. K. Jasani, T. G. Dalakos, P. Grieveson, andW. W. Buchanan. 1968. Clinical studies with an articular index to assessment of joint tenderness in patients with rheumatoid arthritis.Q. J. Med. 37:393–406.
Scott, J., andE. C. Huskisson. 1976. Graphic representation of pain.Pain 2:175–184.
Twomey, B. M., andM. M. Dale. 1992. Cyclooxygenase-independent effects of non-steroidal anti-inflammatory drags on the neutrophil respiratory burst.Biochem. Pharmacol. 43:413–418.
Repo, H., L. Saxen, M. JÄÄttelÄ, M. Ristola, andM. Leirisalo-Repo. 1990. Phagocyte function in juvenile periodontitis.Infect. Immun. 58:1085–1092.
Repo, H., E. Savilahti, andM. Leirisalo-Repo. 1987. Aberrant phagocyte function in Shwachman syndrome.Clin. Exp. Immunol. 69:204–212.
Zigmond, S. H., andJ. Hirsch. 1973. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.J. Exp. Med. 137:387–410.
Boyden, S. 1962. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.J. Exp. Med. 115:453–466.
Wilkinson, P. C. 1974. Chemotaxis and Inflammation. Edinburgh, Churchill Livingstone, Ltd. 168–171.
Koivuranta-Vaara, P., M. Leirisalo-Repo, andH. Repo. 1987. Polymorphonuclear leucocyte function and previous yersinia arthritis: Enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease.Ann. Rheum. Dis. 46:307–313.
Pincus, T. 1988. Rheumatoid arthritis: Disappointing long-term outcomes despite successful short-term clinical trials.J. Clin. Epidemiol. 41:1037–1041.
Reeback, J., andA. Silman. 1984. Predictors of outcome at two years in patients with rheumatoid arthritis.J. R. Soc. Med. 77:1002–1005.
Pamela, L., P. Kurki, T. Helve, andM. Leirisalo-Repo. 1991. Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis.Arthritis Rheum. 34:815–821.
Baccino, E., J. M. Harrewyn, J. Jouquan, H. Swirsky, L. Bressolette, D. Mottier, andP. Youinou. 1987. Ketoprofen-induced reduction of polymorphonuclear cell activation in rheumatoid arthritis.Clin. Exp. Rheumatol. 5:53–57.
Turner, R. A., J. A. Johnson, S. R. Turner, M. Mcgee, andF. Kashanian. 1990. Neutrophil functional and arachidonic acid metabolic correlates and clinical disease activity in pirazolac-treated rheumatoid arthritis patients.Drugs Exp. Clin. Res. 16:39–48.
Repo, H., A. M. M. Jokipii, M. Leirisalo, andT. U. Kosunen. 1980. Leucocyte motility in the newborn: Determination of spontaneous movement is essential in the in vitro assessment of neutrophil chemotaxis.Clin. Exp. Immunol. 40:620–626.
Repo, H., P. Vuopio, M. Leirisalo, S.-E. Jansson, andT. U. Kosunen. 1979. Impaired neutrophil chemotaxis in Pelger-Huet anomaly.Clin. Exp. Immunol. 36:326–333.
Wilkinson, P. C. 1987. Leucocyte locomotion: behavioural mechanisms for accumulation.J. Cell. Sci. 8(Suppl):103–119.
Wilkinson, P. C., andW. S. Haston. 1988. Chemotaxis: An overview.Methods Enzymol. 162:3–16.
Perussia, B., M. Kobayashi, M. E. Rossi, I. Anegon, andG. Trinchieri. 1987. Immune Interferon enhances functional properties of human granulocytes: Role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor.J. Immunol. 138:765–774.
Khwaja, A., J. E. Carver, andD. C. Lich. 1992. Interactions of granulocyte-macrophage colony-stimulating factor (CSF), granulocyte CSF, and tumor necrosis factor alpha in the priming of the neutrophil respiratory burst.Blood 79:745–753.
Cassatella, M. A., F. Bazzoni, R. M. Flynn, S. Dusi, G. Trinchieri, andF. Rossi. 1990. Molecular basis of interferon-gamma and lipopolysaccharide enhancement of phagocyte respiratory burst capability.J. Biol. Chem. 265:20241–20246.
Sadouk, M., C. Vaqueho, B. De La Tour, B. Amor, andA. Toubert. 1990. Interferongamma mRNA expression upon in vitro T lymphocyte activation is decreased in rheumatoid arthritis patients.Clin. Immunol. Immunopathol. 56:37–45.
Gale, R. J., A. Nikoloutsopoulos, J. Bradley, andP. J. Roberts-Thomson. 1985. Immune complex activation of neutrophils and enhancement of the activation by rheumatoid factor and complement.J. Rhewnatol. 12:21–26.
Dechatelet, L. R., G. D. Long, P. S. Shirley, D. A. Bass, M. J. Thomas, F. W. Hen-Derson, andM. S. Cohen. 1982. Mechanism of the luminol-dependent chemiluminescence of human neutrophils.J. Immunol. 129:1589–1593.
Edwards, S. W. 1987. Luminol- and lucigenin-dependent chemiluminescence of neutrophils: Role of degranulation.J. Clin. Lab. Immunol. 22:35–39.
Dahlgren, C., andR. Lock. 1988. The limitation of the human neutrophil chemiluminescence response by extracellular peroxidase is stimulus dependent: Effect of added horse radish peroxidase on the response induced by both soluble and particulate stimuli.J. Clin. Lab. Immunol. 26:49–53.
Dahlgren, C. 1988. Effects on extra- and intracellularly localized, chemoattractant-induced, oxygen radical production in neutrophils following modulation of conditions for ligand-receptor interaction.Inflammation 12:335–349.
Edwards, S. W., V. Hughes, J. Barlow, andR. Bucknall. 1988. Immunological detection of myeloperoxidase in synovial fluid from patients with rheumatoid arthritis.Biochem. J. 250:81–85.
Davies, E. V., B. D. Williams, andA. K. Campbell. 1990. Synovial fluid polymorphonuclear leucocytes from patients with rheumatoid arthritis have reduced MPO and NADPH-oxidase activity.Br. J. Rheumatol. 29:415–421.
Minta, J. O., andM. D. Williams. 1986. Interactions of antirheumatic drugs with the superoxide generation system of activated human polymorphonuclear leukocytes.J. Rheumatol. 13:498–504.
Cuperus, R. A., A. O. Muijsers, andR. Wever. 1985. Antiarthritic drugs containing thiol groups scavenge hypochlorite and inhibit its formation by myeloperoxidase from human leukocytes. A therapeutic mechanism of these drugs in rheumatoid arthritis?Arthritis Rheum. 28:1228–1233.
Mege, J. L., C. Capo, P. Bongrand, P. Richard, andH. Roux. 1986. RÔle des cellules phagocytaires dans la polyarthrite rhumatoÏde.Rev. Rhum. Mal. Osteoartic. 53:55–58.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Leirisalo-Repo, M., Paimela, L., Koskimies, S. et al. Functions of polymorphonuclear leukocytes in early rheumatoid arthritis. Inflammation 17, 427–442 (1993). https://doi.org/10.1007/BF00916583
Issue Date:
DOI: https://doi.org/10.1007/BF00916583